Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
More HIV prevention misinformation is coming from the right.
The Georgia governor erroneously claimed that Americans had refused to get a mandated AIDS vaccine. [VIDEO]
The vaccine regimen tested in the Imbokodo trial was similar to the J&J COVID-19 vaccine, but an mRNA approach may hold more promise.
The experimental vaccines use the same technology as the highly effective Moderna COVID-19 shot.
An experimental vaccine combination did not protect people from acquiring HIV in a large clinical trial.
Providers and advocates reflect on the legacy of AIDS and its implications for COVID-19.
People who received a canarypox vector vaccine regimen were no less likely than placebo recipients to acquire HIV.
Therapeutic HIV vaccines could one day be part of a combination strategy for achieving a functional cure for HIV.
The same messenger RNA (mRNA) technology used for the Moderna and Pfizer-BioNTech COVID-19 vaccines also shows promise for HIV.
#01 Back to the beginning: AIDS and the elusive vaccine
Two experimental vaccine approaches, using mRNA protein delivery and germline targeting, are in the early stages of development.
AVAC’s theme for HVAD 2021 is “HIV Vaccine Research: Building on Lessons from COVID.”
HTI vaccines could become the backbone of a combination approach for achieving a functional cure.
Young people account for 21% of new HIV diagnoses annually. Our April/May issue looks at ways to raise HIV awareness among youth.
I just attended my first CROI (Conference on Retroviruses and Opportunistic Infections). It was also my first virtual conference...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.